A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

Rocky Mountain MS clinic, a Salt Lake City-based provider of specialized care for people living with multiple sclerosis, has ...

While sNfL shows promise as a test for MS patients, Martinez-Serrat cautioned against using it in isolation. "MS is a multifaceted disease, and sNfL is one piece of the puzzle," she said.

Panelists discuss how robust clinical evidence from major studies like the EPIC and OPERA trials demonstrates that ...

Despite resistance from the medical establishment, he found systemic ways to reduce errors, paving the way for a global ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...